Clinical Trial Update: Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

View source ↗

Summary

This update reports the completion of a post-marketing surveillance study of Micardis Plus in patients with hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Micardis Plus (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED